With high regard for China's vast market potential and dynamic innovation ecosystem, Opella, Sanofi's consumer healthcare ...

Sanofi India is divesting its insulin brand, Lantus, with Glenmark, Dr. Reddy's, and Emcure Pharma considering acquisition, though a licensing agreement remains a possibility. The asking price has ...

The key reason I highlight is the ongoing process of spinning off its consumer healthcare unit, which is called Opella. So, on the Q4 earnings call, Francois Roger, Sanofi's CFO, made the ...

Banks including Goldman Sachs Group Inc. and Citigroup Inc. have wrapped up a €7.45 billion ($8.1 billion) sale of leveraged loans and high-yield bonds to finance Clayton Dubilier & Rice’s purchase of ...

In October 2023, Sanofi announced that it intends to separate the Consumer HealthCare unit through the creation of a publicly listed entity headquartered in Paris to be called Opella. Sanofi has ...

In October 2023, Sanofi announced that it intends to separate the Consumer HealthCare unit through the creation of a publicly listed entity headquartered in Paris to be called Opella. Sanofi has ...

The debt package for the unit, which is called Opella, was one of the most hotly anticipated financing deals to come to market this year in Europe and the US. It included €5.2 billion-equivalent ...

Sanofi plans share buybacks, signals more deals post Opella sale Sanofi said on Thursday it would buy back 5 billion euros ($5.21 billion) in shares this year and could be more active with ...

The signing ceremony of the sponsorship agreement between Hope Foundation and Opella Vietnam, part of Sanofi's consumer healthcare division, took place on March 25 in Ho Chi Minh City. This marks the ...